Indeed, correlation of SERPINE2/PN-1 expression levels with survival across the entire human medulloblastoma cohort revealed only a slight difference between low and high expressors; with high SERPINE2/PN-1 expressors surviving slightly better (p = 0.023). This evidence concerns the gene SERPINE2 and medulloblastoma.